Virinchi allots 20.7 lakh shares on warrant conversion to promoter group

Warrants ConvertedFund Raising View source PDF Explain this filing

VIRINCHI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.5%Reaction day

₹21.74

prior close

₹21.40

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.8%-3.7% vs market

Software Products peers, median of 34sector-0.9%-3.6% vs sector

On the reaction day the stock moved 3.7 pts less than Nifty Microcap 250 and 3.6 pts less than its Software Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

-0.3

15m

-0.3

30m

-2.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.5-0.8-3.7-0.9-3.6

Next day

-2.9+1.8-4.7+0.3-3.3

-1.9+2.8-4.7+0.6-2.5

-4.6+2.3-6.8-0.0-4.5

-5.2+1.8-7.0+1.2-6.5

-7.0+0.3-7.3-1.5-5.5

-4.0+0.5-4.5-1.2-2.8

15d

-9.4-2.5-6.9-5.8-3.6

-8.5-6.3-2.1-4.1-4.4

-26.0-8.0-18.0-9.0-17.0

-19.5+8.3-27.8-6.9-12.6

UpDownMarket · Nifty Microcap 250Sector · Software Products peers, median of 34Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Virinchi allotted 20,70,000 equity shares of Rs 10 each at Rs 28 per share (Rs 18 premium) on conversion of warrants issued on a preferential basis. All shares were allotted to Vivo Bio Tech Limited, a promoter group entity. The company received Rs 4.34 crore, being 75 percent of the total issue price. Post-allotment, the issued share capital stands at Rs 107.48 crore divided into 10,74,81,181 equity shares of Rs 10 each.

Likely market impact

Promoter group stake rises with partial equity infusion. Modest dilution for existing public shareholders from conversion of earlier warrants.